Portfolio of Gene Editing (CRISPR) Stocks
Here are 4 gene editing stocks that use CRISPR technology.
|4 Portfolio of Gene Editing (CRISPR) Stocks|
Stock Returns & Price Chart
Recent Prices &
|Price data from Quandl as of most recent close.|
stocks are included in the portfolio computations. The current value of the portfolio assumes that $2,500.00 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends.
To inspect the performance of the Portfolio of Gene Editing (CRISPR) Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.
The current value of a $10,000 investment is $15,757. The percent return is 57.57%. The annualized return is 25.53%.